Lifetime prevalence estimates of major depression: An indirect estimation method and a quantification of recall bias

Kruijshaar, Michelle E.; Barendregt, Jan J.; Vos, Theo; Graaf, Ron de; Spijker, Jan; Andrews, Gavin

doi:10.1007/s10654-004-1009-0

Cited by 195 publications

(158 citation statements)

References 34 publications

Supporting

Mentioning

148

Contrasting

Unclassified

Order By: Relevance

“…These prevalences may be even higher as cross-sectional surveys are biased by recall problems. When recall bias is considered, the prevalence of lifetime MDD is estimated at 30% in men and 40% in women (Kruijshaar et al, 2005). These disorders constitute a huge public health problem, mainly due to the chronic and disabling course, but in the case of MDD, also as a result of the increased risk for other major diseases such as cardiac mortality (Musselman et al, 1998;Penninx et al, 2001).…”

mentioning

confidence: 99%

Familial Clustering of Major Depression and Anxiety Disorders in Australian and Dutch Twins and Siblings

et al. 2005

View full text Add to dashboard Cite

T he aim of this study was to investigate familial influences and their dependence on sex for panic disorder and/or agoraphobia, social phobia, generalized anxiety disorder and major depression. Data from Australian (N = 2287) and Dutch (N = 1185) twins and siblings who were selected for a linkage study and participated in clinical interviews to obtain lifetime Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) diagnoses were used. In a liability model, tetrachoric correlations were estimated in sibling pairs and sex differences between sibling correlations were tested. For each diagnosis, the sibling correlations could be constrained to be equal across the Australian and Dutch samples. With the exception of panic disorder and/or agoraphobia, all sibling correlations were the same for brother, sister and opposite-sex sibling pairs and were around .20. For panic disorder and/or agoraphobia, the correlation was .23 in brother and sister pairs, but absent in opposite-sex sibling pairs. From these results it can be concluded that upper heritability estimates, based on twice the correlations in the sibling pairs, vary between 36% (major depression) and 50% (social phobia). Furthermore, different genetic risk factors appear to contribute to the vulnerability for panic disorder and/or agoraphobia in men and women. No other sex differences were found.Anxiety disorders and major depression (MDD) are common disorders. In epidemiological studies, lifetime prevalences in women are found to be around 30% for some kind of anxiety disorders and around 20% for MDD (Bijl et al., 1998;Kessler et al., 1994). Although these prevalences are lower in men, they are still high with figures ranging between 14% and 19% for anxiety disorders and between 11% and 13% for MDD (Bijl et al., 1998;Kessler et al., 1994). These prevalences may be even higher as cross-sectional surveys are biased by recall problems. When recall bias is considered, the prevalence of lifetime MDD is estimated at 30% in men and 40% in women (Kruijshaar et al., 2005). These disorders constitute a huge public health problem, mainly due to the chronic and disabling course, but in the case of MDD, also as a result of the increased risk for other major diseases such as cardiac mortality (Musselman et al., 1998;Penninx et al., 2001).Consequently, the etiology of these disorders is an important topic of research. Over the last 20 years, several family and twin studies have been performed to investigate the influence of familial factors on anxiety and depression. In the description of the results, we will focus on MDD, panic disorder and/or agoraphobia, social phobia and generalized anxiety disorder (GAD). Sullivan et al. (2000) and Hettema, Neale, et al. (2001) discussed the results of family and twin studies on lifetime diagnoses of MDD and anxiety disorders respectively and performed a metaanalysis when possible. They included studies in which the disorders were defined by operationalized diagnostic criteria, such as the Diagnostic and Statistical Man...

show abstract

mentioning

confidence: 99%

Familial Clustering of Major Depression and Anxiety Disorders in Australian and Dutch Twins and Siblings

et al. 2005

View full text Add to dashboard Cite

show abstract

“…10 On the basis of 3 prospective cohorts followed from birth to 26 years, 11 from 24 to 50 years, 12 and from 70 to 85 years 13 we have estimated that at least one-half the population will experience at least one MDE during their lifetime.…”

Section: Epidemiologymentioning

confidence: 99%

Reducing the Burden of Depression

Andrews

2008

Can J Psychiatry

Self Cite

View full text Add to dashboard Cite

M DE is identified as prevalent, disabling, and a major determinant in the burden of disease. Nevertheless, waiting rooms are not full of individuals whose primary complaint is depression. How can this be? I will use data from the Australian NMHWS to illustrate some of the issues. MDE is a syndrome of low mood, loss of interest, and other symptoms. There are no laboratory tests for MDE and diagnosis has depended on a trained clinician asking individuals about their symptoms. The DSM-IV 1 lists 5 criteria to satisfy the diagnosis. The first criterion lists 9 symptoms, 5 of which must be present and at least 1 of the 5 must be depressed mood or loss of interest or pleasure for the diagnosis to be met. All must be judged to be significant by an experienced clinician in terms of severity, duration, abnormality, distress, and impairment. In addition, the diagnosis requires that the symptoms do not present as a mixed manic episode and MDE, do cause clinically significant distress and are not owing to substance use, general medical condition, bereavement, psychosis, and that there has never been a hint of mania. A total of 20 pieces of information is required before a clinician can safely make the diagnosis.

show abstract

“…A depressão é um dos maiores problemas de saúde pública no mundo ( KRUIJSHAAR et al, 2005). Sua etiologia não é completamente conhecida, além dos fatores psicossociais, diferentes fatores biológicos e ambientais são considerados para desencadear a fisiopatologia (SAVEANU;NEMEROFF, 2012).…”

Section: Introductionunclassified

Influência dos ácidos graxos ômega 3 e vitamina D na depressão: uma breve revisão

Rosa¹,

Saraiva

Real

et al. 2017

cmbio

View full text Add to dashboard Cite

ResumoObjetivo: descrever uma revisão da literatura sobre a importância dos ácidos graxos ômega-3 e da vitamina D na prevenção e tratamento da depressão. Metodologia: essa revisão foi feita no período de agosto, setembro de 2016, incluindo as publicações de 2000 a 2016. Procedeu-se a busca nas bases de dados Pubmed, Science Direct, Bireme e periódicos CAPES com a utilização dos descritores: "ômega-3", "docosahexaenoic acid", "DHA", "eicosapentaenoic acid", "EPA", "vitamin D" e "depression". Resultados: a literatura reporta vários estudos sobre a eficácia dos ácidos graxos ômega-3 no tratamento da depressão. No entanto, existe um número considerável de trabalhos que não demonstram eficácia dos ácidos graxos ômega-3 na depressão. Os fatores responsáveis pelos resultados variados são: modelos experimentais, diferenças de tamanho da amostra, diferenças biológicas e genéticas entre os doentes, a variabilidade ambiental, e variabilidade na resposta à ácidos graxos ômega-3. Em relação a vitamina D, os resultados também são contraditórios, com evidências sugerindo que baixos níveis dessa vitamina podem estar associados a um maior risco de depressão.

show abstract

Lifetime prevalence estimates of major depression: An indirect estimation method and a quantification of recall bias

Cited by 195 publications

References 34 publications

Familial Clustering of Major Depression and Anxiety Disorders in Australian and Dutch Twins and Siblings

Familial Clustering of Major Depression and Anxiety Disorders in Australian and Dutch Twins and Siblings

Reducing the Burden of Depression

Influência dos ácidos graxos ômega 3 e vitamina D na depressão: uma breve revisão

Contact Info

Product

Resources

About